Literature DB >> 16200487

Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in childhood.

M Emmel1, N Sreeram, J V deGiovanni, K Brockmeier.   

Abstract

Two patients, a 5 year old boy with progressive hypertrophic obstructive cardiomyopathy and increasing symptoms despite appropriate pharmacologic therapy and an 11 year old girl with symptoms of tiredness and peak instantaneous LVOT gradient of 80 and 90 mmHg respectively were considered for radiofrequency catheter septal ablation, to relieve the left ventricular outflow tract obstruction. Via a femoral arterial approach, the His bundle was initially plotted and marked using the LocaLisa navigation system. Subsequently, using a cooled tip catheter a series of lesions was placed in the hypertrophied septum, commencing distally in the ventricle and proceeding towards the aortic valve, taking care to stay away from the His bundle. The procedure was deemed to be completed when the entire extent of the hypertrophied septum had been treated. In the boy the procedure was complicated by two episodes of ventricular fibrillation, requiring DC cardioversion, but without any neurologic sequelae. The peak to peak gradient between left ventricle and aorta was 50 mmHg and 60 mmHg respectively pre-ablation, and remained unchanged immediately after. Both patients were discharged from the hospital 48 hours later. Serial measurement of serum Troponin T and CK-MB isoenzyme confirmed significant myocardial necrosis. Follow-up echocardiography at 7 days and at 6 weeks post-ablation respectively confirmed a beneficial hemodynamic result, with reduction of left ventricular outflow obstruction and relief of symptoms. In young children, in whom alcohol induced septal ablation is not an option, radiofrequency catheter ablation offers an alternative to surgery, with the benefits of repeatability and a lower risk of procedure-related permanent AV block.

Entities:  

Mesh:

Year:  2005        PMID: 16200487     DOI: 10.1007/s00392-005-0282-6

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  10 in total

Review 1.  Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.

Authors:  H Kuhn; F H Gietzen; C Leuner; M Schäfers; O Schober; C Strunk-Müller; L Obergassel; M Freick; B Gockel; F Lieder; U Raute-Kreinsen
Journal:  Z Kardiol       Date:  2000

2.  Approach to Hypertrophic Cardiomyopathy.

Authors:  Camillo Autore; Paolo Spirito; Paolo Spirito
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-12

Review 3.  Hypertrophic cardiomyopathy in childhood.

Authors:  Barry J Maron
Journal:  Pediatr Clin North Am       Date:  2004-10       Impact factor: 3.278

4.  Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.

Authors:  T Lawrenz; H Kuhn
Journal:  Z Kardiol       Date:  2004-06

5.  Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae.

Authors:  Kenji Minakata; Joseph A Dearani; Rick A Nishimura; Barry J Maron; Gordon K Danielson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 5.209

6.  [Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy].

Authors:  L Faber; H Seggewiss; D Welge; D Fassbender; P Ziemssen; H K Schmidt; U Gleichmann; D Horstkotte
Journal:  Z Kardiol       Date:  2003-01

7.  Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry.

Authors:  H Kuhn; H Seggewiss; F H Gietzen; P Boekstegers; L Neuhaus; L Seipel
Journal:  Z Kardiol       Date:  2004-01

8.  Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

Authors:  Barry J Maron; Susan A Casey; Robert G Hauser; Dorothee M Aeppli
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

Review 9.  New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard?

Authors:  Otto M Hess; Ulrich Sigwart
Journal:  J Am Coll Cardiol       Date:  2004-11-16       Impact factor: 24.094

Review 10.  The case for surgery in obstructive hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Joseph A Dearani; Steve R Ommen; Martin S Maron; Hartzell V Schaff; Bernard J Gersh; Rick A Nishimura
Journal:  J Am Coll Cardiol       Date:  2004-11-16       Impact factor: 24.094

  10 in total
  5 in total

1.  Paediatric electrophysiologic studies: how and what with?

Authors:  N Sreeram; M Emmel; U Trieschmann; E de Haan
Journal:  Indian Pacing Electrophysiol J       Date:  2008-05-01

Review 2.  Current status and future perspectives on alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Rami N Khouzam; Srihari S Naidu
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

Review 3.  [Anaesthesia for cardiac catheterization in children].

Authors:  C Velik-Salchner; J Margreiter; V Wenzel; P Mair
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

4.  Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.

Authors:  Haonan Yang; Yuan Yang; Yuzhou Xue; Suxin Luo
Journal:  Clin Cardiol       Date:  2020-02-07       Impact factor: 2.882

Review 5.  Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy.

Authors:  Tolga Aksu; Tümer Erdem Güler; Kıvanç Yalın; Şükriye Ebru Gölcük; Kazım Serhan Özcan
Journal:  Anatol J Cardiol       Date:  2016-09       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.